RXi Pharmaceuticals Corp. of Worcester has begun trading on the OTC Bulletin Board, marking the final step in its spin-off from Galena Biopharma Inc. The company, which is developing therapies based ...
RXi shares plunged 25% this morning. In the split, institutional investors agreed to invest $9.5 million in RXi Pharmaceuticals and $2.5 million in Galena Biopharma. Galena also retains a minority ...
Galena Biopharma Inc. has set the day to spin off RXi Pharmaceuticals Corp. Oregon-based Galena said today a spin-off stock dividend of shares in RXi Pharmaceuticals Corp. of Worcester is payable as ...
Institutional investors purchase $2.5 million worth of new cancer entity common stock and an 83% stake in spin-out. RXi Therapeutics is restructuring and splitting into two public traded companies ...
On December 18, 2012, Galena Biopharma (GALE) priced an underwritten public offering of 15,156,250 units at a public offering price of $1.60 per unit with total gross proceeds of $24.25 million. Each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback